keisuke katsushima

Employment

• St. Jude Children's Research Hospital Associate Scientist
  2025 - Present
• KEISUKE KATSUHSIMA
  2018 - 2019
• KEISUKE KATSUHSIMA
  2017 - 2018
• KEISUKE KATSUHSIMA
  2015 - 2017

Education

Education history is unavailable.

Projects & Funding

• Global analysis of long non-coding RNA during gliomagenesis Japan Society for the Promotion of Science
  2017 - 2019
• Study of regulatory mechanism controlling cancer cell reprogramming Japan Society for the Promotion of Science
  2013 - 2017

Publications (59)

• Supplementary Data from Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer
  2025 DOI: 10.1158/0008-5472.22428666
  +Save
• Novel pharmacologic inhibition of lysine-specific demethylase 1 as a potential therapeutic for glioblastoma
  Cancer Gene Therapy 2024 DOI: 10.1038/s41417-024-00847-8
  +Save
• Data from Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer
  2023 DOI: 10.1158/0008-5472.c.6513096
  +Save
• Diagnostic and therapeutic potential of circular RNA in brain tumors
  Neuro-Oncology Advances 2023 DOI: 10.1093/noajnl/vdad063
  +Save
• The long non-coding RNA SPRIGHTLY and its binding partner PTBP1 regulate exon 5 skipping of SMYD3 transcripts in group 4 medulloblastomas
  Bongyong Lee, Keisuke Katsushima, Rudramani Pokhrel +7 more
  Neuro-Oncology Advances 2022 DOI: 10.1093/noajnl/vdac120
  +Save
• Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer
  Cancer Research 2021 DOI: 10.1158/0008-5472.CAN-20-3021
  +Save
• The long noncoding RNA lnc-HLX-2-7 is oncogenic in Group 3 medulloblastomas.
  Neuro-oncology 2021 DOI: 10.1093/neuonc/noaa235
  +Save
• Long non-coding RNAs in brain tumors
  NAR Cancer 2021 DOI: 10.1093/narcan/zcaa041
  +Save
• LncRNA TUG1 is a potent therapeutic target via enhancing 5-FU sensitivity in pancreatic cancer
  Cancer Science 2021
  +Save
• MICRORNA 211, A POTENTIAL THERAPEUTIC AGENT FOR GROUP 3 MEDULLOBLASTOMA IN CHILDREN
  Neuro-Oncology 2021
  +Save
• Unit polyion complex (uPIC) nanocarrier for siRNA delivery to glioblastoma and pancreatic cancer
  Cancer Science 2021
  +Save
• Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphoma
  Oncogene 2020 DOI: 10.1038/s41388-020-01393-x
  +Save
• A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
  PloS one 2020 DOI: 10.1371/journal.pone.0233782
  +Save
• The Emerging Field of Noncoding RNAs and Their Importance in Pediatric Diseases
  The Journal of Pediatrics 2020 DOI: 10.1016/j.jpeds.2020.02.078
  +Save
• MYC REGULATED LONG NONCODING RNA LNC-HLX-2-7 IS A PUTATIVE MOLECULAR MARKER AND A THERAPEUTIC TARGET FOR GROUP 3 MEDULLOBLASTOMAS IN CHILDREN
  Neuro-Oncology 2020
  +Save
• Pathogenic Epigenetic Consequences of Genetic Alterations in IDH-Wild-Type Diffuse Astrocytic Gliomas.
  Cancer research 2019 DOI: 10.1158/0008-5472.can-19-1272
  +Save
• Identification of a chemical modulator of EZH2-mediated silencing by cell-based high-throughput screening assay.
  Journal of biochemistry 2019 DOI: 10.1093/jb/mvz007
  +Save
• The therapeutic and diagnostic potential of regulatory noncoding RNAs in medulloblastoma.
  Neuro-oncology advances 2019 DOI: 10.1093/noajnl/vdz023
  +Save
• In vivo rendezvous of small nucleic acid drugs with charge-matched block catiomers to target cancers.
  Nature communications 2019 DOI: 10.1038/s41467-019-09856-w
  +Save
• ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer.
  Cancer science 2019 DOI: 10.1111/cas.13936
  +Save